How to decide impurities in API & Drug Products and their release and shelf life specification

  Рет қаралды 13,452

Pharma Growth Hub

Pharma Growth Hub

Күн бұрын

Пікірлер: 20
@glorya2908
@glorya2908 6 ай бұрын
Thanks for good information sir
@tamizhselvan655
@tamizhselvan655 3 жыл бұрын
Hello sir. I am working in analytical research and development your videos are very useful for me thank you and keep continuing your effort sir...I am come to lot of this after seeing your videos.🙂
@sambhajimasal4248
@sambhajimasal4248 3 жыл бұрын
SUNDAY morning Motivation 🤩 Thanks for Your continuous efforts,
@ramanbissa
@ramanbissa 3 жыл бұрын
very nice effort, it is the first channel of it's kind...
@pharmagrowthhub3083
@pharmagrowthhub3083 3 жыл бұрын
Thanks a lot 😊
@khusvikavlogs6958
@khusvikavlogs6958 Жыл бұрын
Great work sir i get lot of motivation and knowledge from your videos
@sulakshamunnolli348
@sulakshamunnolli348 2 жыл бұрын
Perfect lecture ....thanks Bhaskar...hope you are doing great
@neetawagh442
@neetawagh442 4 ай бұрын
SIR, how to perform dose formation analysis?
@rahulkulkarni3037
@rahulkulkarni3037 2 жыл бұрын
Where can we get registered specification of impurities ANDA or NDA?
@karnakarkadaru2317
@karnakarkadaru2317 3 жыл бұрын
Hi sir, I could not get clarity on this topic. If we have to qulifiy Impurity specification rather than release specification. What is the criteria as per guidline and how much level of imp is safety. What are the doccument should be generate to getting the self-life specification. Please make a video by elaborating the topic. Thanking you sir
@astaspadiene7346
@astaspadiene7346 Жыл бұрын
Hello, I am writing to you from the Lithuania University of Health Science. I would like to ask your permission to use this video in my lecture and show it to my students. The video will be shown for educational purposes only. I look forward to hearing from you and hope you will agree to share your presentation. Kind Regards, Asta Špadienė
@pharmagrowthhub3083
@pharmagrowthhub3083 Жыл бұрын
Sure, Asta!
@ShivamChauhan-xu5cd
@ShivamChauhan-xu5cd 3 жыл бұрын
Learning is a treasure that will follow its owner everywhere... Thanks a lot... (How can I connect with you? Kindly share details )
@syedmujeeba884
@syedmujeeba884 8 ай бұрын
dear sir, Please explain on refernce stnadrds, primary standard , working standard, compendial standards
@yogeshmandole5953
@yogeshmandole5953 2 жыл бұрын
On what basis you decide to qualify 1.5% for shelf life limit, why not 2%
@durgaprasad-fs2qf
@durgaprasad-fs2qf 2 жыл бұрын
Dear sir, pls refer me where I have to find out the information about all known impurities limits,TD50,LD50 values ?
@shantanreddy6487
@shantanreddy6487 3 жыл бұрын
Super sir
@dhivyasivarajan5393
@dhivyasivarajan5393 2 жыл бұрын
Hi, Your videos are very helpful and easy to understand. Only request/suggestion would be order the video content as it would make the viewers to have a flow in the content. Great job and thanks for the effort!
10 Step Control Strategy to Avoid Nitrosamine Impurities
12:24
Pharma Growth Hub
Рет қаралды 7 М.
What is Photostability and how to conduct it?
17:09
Pharma Growth Hub
Рет қаралды 9 М.
Интересно, какой он был в молодости
01:00
БЕЗУМНЫЙ СПОРТ
Рет қаралды 3,7 МЛН
[BEFORE vs AFTER] Incredibox Sprunki - Freaky Song
00:15
Horror Skunx 2
Рет қаралды 19 МЛН
Леон киллер и Оля Полякова 😹
00:42
Канал Смеха
Рет қаралды 4,1 МЛН
How to Remove Carryover in HPLC?
12:21
Pharma Growth Hub
Рет қаралды 8 М.
Evaluation of Elemental Impurities in Drugs and Drug Products ICH Q3D(R2)
57:15
Dissolution method development for Immediate Release (IR) drug product
15:47
Total Impurity Specification and Acceptance Criteria
23:44
Pharma Learning In Depth
Рет қаралды 1,8 М.
How to define limit for unknown, known and total impurities
26:07
Pharma Growth Hub
Рет қаралды 59 М.
How to decide the Dissolution Specification of an IR product?
14:51
Pharma Growth Hub
Рет қаралды 5 М.
How to conduct forced degradation study?
20:04
Pharma Growth Hub
Рет қаралды 21 М.
SPECIFICATION OF IN-HOUSE PRODUCTS
13:11
EASY QUALITY LEARNING
Рет қаралды 8 М.